Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Viveve.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accelerate Diagnostics, Aranet, Beyond Air, CDC, Biobeats, Biocheck Biofourmis, Co-Vents, Co-Diagnostics, Microsoft, Electronic Caregiver, Elucid Bioimaging, Gaido Health, Huma, Immunecyte Life Sciences, MD Revolution, Milestone Scientific, Moleculight, OralDNA Labs, Proximo Medical, Renesas Electronics, Takeda Pharmaceuticals, Thermogenesis Holdings, Tlt, Vayyar, Vyaire Medical, Xenex Disinfection Services.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Zhejiang Orient Gene Biotech.

Med-tech firms raising money in public or private financings, including: Athersys, Invivo Therapeutics, Reflexion.

New hires and promotions in the med-tech industry, including: Ancestry, Sphingotec.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alphamab, Ascendis, Autolus, Eagle, Emmaus, Index, Mayne, Mithra, Provention, Regeneron, Tetra, Tissuetech, Zai.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acucela, Aeterna, Al Vivo, Atlas, Azurrx, Batavia, Biogen, Biohaven, Botanix, Cerespir, Cevec, Clinigen, Dynavax, Eagle, Elicio, Evotec, Evox, Fairjourney, F-star, Fusion Antibodies, Galapagos, Immutep, Iksuda, Inovio, Iontas, Jaguar, Kubota, Legochem, Leo, Leon-Nanodrugs, Medison, Napo, Novartis, Octapharma, PDS, Porton, Pulmatrix, Ryvu, SAB, Scitech, Sinovac, Soligenix, Starpharma, Synthon, Turning Point, Urogen, Valbiotis, Vivoryon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Adial, Affimed, Amag, Biosig, Indivior, Inovio, Magenta, Novavax, Nucleus, PDS, Roivant, Sunovion, Vir.

Biopharmas raising money in public or private financings, including: Arcturus Therapeutics, Athersys, Calithera Biosciences, Evotec, Leon-nanodrugs.

New hires and promotions in the biopharma industry, including: Imago, Ohana, Pharnext, Solid, Stipe, Tearclear, Themis.